Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1967 1
1982 1
1988 2
1990 1
1992 1
2000 3
2002 7
2003 11
2004 5
2005 10
2006 15
2007 16
2008 20
2009 28
2010 33
2011 17
2012 13
2013 13
2014 8
2015 13
2016 7
2017 2
2018 9
2019 13
2020 14
2021 13
2022 14
2023 9
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

270 results

Results by year

Filters applied: . Clear all
Page 1
A First-in-Human Phase I Study of Milademetan, an MDM2 Inhibitor, in Patients With Advanced Liposarcoma, Solid Tumors, or Lymphomas.
Gounder MM, Bauer TM, Schwartz GK, Weise AM, LoRusso P, Kumar P, Tao B, Hong Y, Patel P, Lu Y, Lesegretain A, Tirunagaru VG, Xu F, Doebele RC, Hong DS. Gounder MM, et al. Among authors: weise am. J Clin Oncol. 2023 Mar 20;41(9):1714-1724. doi: 10.1200/JCO.22.01285. Epub 2023 Jan 20. J Clin Oncol. 2023. PMID: 36669146 Free PMC article. Clinical Trial.
Non-Invasive Prenatal Testing in Germany.
Liehr T, Harutyunyan T, Williams H, Weise A. Liehr T, et al. Among authors: weise a. Diagnostics (Basel). 2022 Nov 16;12(11):2816. doi: 10.3390/diagnostics12112816. Diagnostics (Basel). 2022. PMID: 36428876 Free PMC article. Review.
Phase I Study of Elacestrant (RAD1901), a Novel Selective Estrogen Receptor Degrader, in ER-Positive, HER2-Negative Advanced Breast Cancer.
Bardia A, Kaklamani V, Wilks S, Weise A, Richards D, Harb W, Osborne C, Wesolowski R, Karuturi M, Conkling P, Bagley RG, Wang Y, Conlan MG, Kabos P. Bardia A, et al. Among authors: weise a. J Clin Oncol. 2021 Apr 20;39(12):1360-1370. doi: 10.1200/JCO.20.02272. Epub 2021 Jan 29. J Clin Oncol. 2021. PMID: 33513026 Free PMC article. Clinical Trial.
Noninvasive Prenatal Testing - When Is It Advantageous to Apply.
Liehr T, Lauten A, Schneider U, Schleussner E, Weise A. Liehr T, et al. Among authors: weise a. Biomed Hub. 2017 Mar 4;2(1):1-11. doi: 10.1159/000458432. eCollection 2017 Jan-Apr. Biomed Hub. 2017. PMID: 31988902 Free PMC article. Review.
Microdeletion and microduplication syndromes.
Weise A, Mrasek K, Klein E, Mulatinho M, Llerena JC Jr, Hardekopf D, Pekova S, Bhatt S, Kosyakova N, Liehr T. Weise A, et al. J Histochem Cytochem. 2012 May;60(5):346-58. doi: 10.1369/0022155412440001. Epub 2012 Mar 6. J Histochem Cytochem. 2012. PMID: 22396478 Free PMC article. Review.
Assessing Skewed X-Chromosome Inactivation.
Liehr T, Ziegler M, Löhmer S, Weise A. Liehr T, et al. Among authors: weise a. Curr Protoc Hum Genet. 2018 Jul;98(1):e66. doi: 10.1002/cphg.66. Epub 2018 Jul 10. Curr Protoc Hum Genet. 2018. PMID: 29989334
Safety outcomes of direct oral anticoagulants in older adults with atrial fibrillation: a systematic review and meta-analysis of (subgroup analyses from) randomized controlled trials.
Doni K, Bühn S, Weise A, Mann NK, Hess S, Sönnichsen A, Salem S, Pieper D, Thürmann P, Mathes T. Doni K, et al. Among authors: weise a. Geroscience. 2024 Feb;46(1):923-944. doi: 10.1007/s11357-023-00825-2. Epub 2023 Jun 1. Geroscience. 2024. PMID: 37261677 Free PMC article.
Reorganization of inter-chromosomal interactions in the 2q37-deletion syndrome.
Maass PG, Weise A, Rittscher K, Lichtenwald J, Barutcu AR, Liehr T, Aydin A, Wefeld-Neuenfeld Y, Pölsler L, Tinschert S, Rinn JL, Luft FC, Bähring S. Maass PG, et al. Among authors: weise a. EMBO J. 2018 Aug 1;37(15):e96257. doi: 10.15252/embj.201696257. Epub 2018 Jun 19. EMBO J. 2018. PMID: 29921581 Free PMC article.
270 results